![]() |
|
|
Vol. 281, Issue 2, 785-790, 1997
Medical (J.L.H.) and
Research (R.R.E.) Services, We have previously found that for acetaminophen kinetic differences
exist between the hepatic microsomal catalyzed protein binding and
cysteine conjugation. We have also observed that the protein binding of
acetaminophen is only to intralumenal proteins. Together these data
suggested that two pools of the reactive metabolite, N-acetyl-p-benzoquinone imine (NABQI), are formed during
the oxidative metabolism of acetaminophen: one on the cytosolic surface
and the other within the lumen of the microsomes. This would indicate that some of forms of cytochrome P450 (CYP) catalyzing NABQI formation have their active site on the cytosolic surface and others on the
lumenal surface. We have examined this question by comparing the rates
of cysteine conjugation and protein binding of acetaminophen by
microsomes from lymphoblasts tranfected with the cDNAs for human CYPs.
We found that CYP2D6 catalyzed only cysteine conjugation; CYP1A2 and
3A4 catalyzed only protein binding; CYP2E1 catalyzed both; and CYP1A1,
CYP2A6 and CYP2B6 catalyzed neither. These data suggest that CYP2D6 has
its active site only on the cytosolic surface; CYP1A2 and CYP3A4 only
on the lumenal surface; and CYP2E1 has catalytic sites on both the
lumenal and cytosolic surfaces of the membrane. In mouse studies we
have found that ethanol administration increased acetaminophen protein
binding by 265% but cysteine conjugation by only 61%. CYP2E1 and
CYP2B increased, whereas CYP3A decreased and the others did not change.
These data suggest that in control mice CYP2E1 catalyzes the bulk of
protein binding, whereas CYP2D catalyzes slightly more cysteine
conjugation than does CYP2E1.
Copyright © by The American Society for Pharmacology and Experimental Therapeutics